Antimicrobial activity of ceftazidime-avibactam tested against Pseudomonas aeruginosa from China (2009-2010)

被引：0
|
作者：
Flamm, R. K. [1 ]
Jones, R. N. [1 ]
Sader, H. S. [1 ]
Wang, Y. [2 ]
Xu, Y. [2 ]
机构：
[1] JMI Labs, North Liberty, IA USA
[2] Peking Union Hosp, Beijing, Peoples R China
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2013年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
下载
收藏
页码：S62 / S62
页数：1
相关论文
共 50 条
  • [21] Antimicrobial Activity of Ceftolozane-Tazobactam, Ceftazidime-Avibactam, and Cefiderocol against Multidrug-Resistant Pseudomonas aeruginosa Recovered at a German University Hospital
    Weber, C.
    Schultze, T.
    Goettig, S.
    Kessel, J.
    Schroeder, A.
    Tietgen, M.
    Besier, S.
    Burbach, T.
    Haeussler, S.
    Wichelhaus, T. A.
    Hack, D.
    Kempf, V. A. J.
    Hogardt, M.
    MICROBIOLOGY SPECTRUM, 2022, 10 (05):
  • [22] In Vitro Activity of Ceftazidime-Avibactam against Contemporary Pseudomonas aeruginosa Isolates from US Medical Centers by Census Region, 2014
    Huband, Michael D.
    Castanheira, Mariana
    Flamm, Robert K.
    Farrell, David J.
    Jones, Ronald N.
    Sader, Helio S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (04) : 2537 - 2541
  • [23] KPC variants conferring resistance to ceftazidime-avibactam in Pseudomonas aeruginosa strains
    Hu, Yanyan
    Shen, Weiyi
    Lin, Di
    Wu, Yuchen
    Zhang, Yanyan
    Zhou, Hongwei
    Zhang, Rong
    MICROBIOLOGICAL RESEARCH, 2024, 289
  • [24] First Study of Antimicrobial Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Pseudomonas aeruginosa Isolated from Patients with Urinary Tract Infection in Tehran, Iran
    Rahimzadeh, Mohammad
    Habibi, Mehri
    Bouzari, Saeid
    Karam, Mohammad Reza Asadi
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 533 - 541
  • [25] Assessment of 30/20-Microgram Disk Content versus MIC Results for Ceftazidime-Avibactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa
    Sader, Helio S.
    Rhomberg, Paul R.
    Huband, Michael D.
    Critchley, Ian A.
    Stone, Gregory G.
    Flamm, Robert K.
    Jones, Ronald N.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2018, 56 (06)
  • [26] Activity of aztreonam in combination with ceftazidime-avibactam against serine- and metallo-β-lactamase-producing Pseudomonas aeruginosa
    Lee, Michelle
    Abbey, Taylor
    Biagi, Mark
    Wenzler, Eric
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2021, 99 (01)
  • [27] Antimicrobial activity of ceftazidime/avibactam, ceftolozane/tazobactam and comparator agents against Pseudomonas aeruginosa from cystic fibrosis patients
    Sader, Helio S.
    Duncan, Leonard R.
    Doyle, Timothy B.
    Castanheira, Mariana
    JAC-ANTIMICROBIAL RESISTANCE, 2021, 3 (03):
  • [28] Ceftazidime-Avibactam Activity against Multidrug-Resistant Pseudomonas aeruginosa Isolated in US Medical Centers in 2012 and 2013
    Sader, Helio S.
    Castanheira, Mariana
    Mendes, Rodrigo E.
    Flamm, Robert K.
    Farrell, David J.
    Jones, Ronald N.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (06) : 3656 - 3659
  • [29] Evaluation of the In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Meropenem-Resistant Pseudomonas aeruginosa Isolates
    Buehrle, Deanna J.
    Shields, Ryan K.
    Chen, Liang
    Hao, Binghua
    Press, Ellen G.
    Alkrouk, Ammar
    Potoski, Brian A.
    Kreiswirth, Barry N.
    Clancy, Cornelius J.
    Nguyen, M. Hong
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (05) : 3227 - 3231
  • [30] Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the In Vitro Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa
    Yin, Dandan
    Wu, Shi
    Yang, Yang
    Shi, Qingyu
    Dong, Dong
    Zhu, Demei
    Hu, Fupin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (04)
12345